Vistagen Therapeutics, Inc. Quarterly Debt-to-equity in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Vistagen Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q4 2011 to Q3 2024.
  • Vistagen Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 8.14 %, a 81.3% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 8.14 -35.4 -81.3% Sep 30, 2024
Q2 2024 8.58 -45.4 -84.1% Jun 30, 2024
Q1 2024 11.4 -27.2 -70.5% Mar 31, 2024
Q4 2023 17.7 -8.81 -33.2% Dec 31, 2023
Q3 2023 43.6 +23.5 +117% Sep 30, 2023
Q2 2023 53.9 +34.4 +176% Jun 30, 2023
Q1 2023 38.6 +19.7 +105% Mar 31, 2023
Q4 2022 26.5 +7.32 +38.1% Dec 31, 2022
Q3 2022 20.1 +0.23 +1.16% Sep 30, 2022
Q2 2022 19.5 -4.45 -18.6% Jun 30, 2022
Q1 2022 18.9 -13.5 -41.7% Mar 31, 2022
Q4 2021 19.2 -44 -69.6% Dec 31, 2021
Q3 2021 19.9 +404 Sep 30, 2021
Q2 2021 24 +247 Jun 30, 2021
Q1 2021 32.3 +369 Mar 31, 2021
Q4 2020 63.2 +4.17K Dec 31, 2020
Q3 2020 -384 -923 -171% Sep 30, 2020
Q2 2020 -223 -425 -211% Jun 30, 2020
Q1 2020 -337 -479 -337% Mar 31, 2020
Q4 2019 -4.11K -4.23K -3328% Dec 31, 2019
Q3 2019 539 +464 +619% Sep 30, 2019
Q2 2019 202 +107 +114% Jun 30, 2019
Q1 2019 142 +36.9 +35.1% Mar 31, 2019
Q4 2018 127 -40.3 -24.1% Dec 31, 2018
Q3 2018 74.9 -1.41K -94.9% Sep 30, 2018
Q2 2018 94.3 -90.6 -49% Jun 30, 2018
Q1 2018 105 +16.6 +18.8% Mar 31, 2018
Q4 2017 168 +37.9 +29.2% Dec 31, 2017
Q3 2017 1.48K +1.25K +541% Sep 30, 2017
Q2 2017 185 -4.94K -96.4% Jun 30, 2017
Q1 2017 88.6 +265 Mar 31, 2017
Q4 2016 130 +252 Dec 31, 2016
Q3 2016 231 +341 Sep 30, 2016
Q2 2016 5.12K +5.23K Jun 30, 2016
Q1 2016 -176 -73.8 -72.1% Mar 31, 2016
Q4 2015 -123 -20 -19.5% Dec 31, 2015
Q3 2015 -110 -6.84 -6.64% Sep 30, 2015
Q2 2015 -105 -1.19 -1.15% Jun 30, 2015
Q1 2015 -102 +0.54 +0.53% Mar 31, 2015
Q4 2014 -103 +0.78 +0.75% Dec 31, 2014
Q3 2014 -103 +0.45 +0.44% Sep 30, 2014
Q2 2014 -103 +0.72 +0.69% Jun 30, 2014
Q1 2014 -103 +2.4 +2.28% Mar 31, 2014
Q4 2013 -103 +28.1 +21.4% Dec 31, 2013
Q3 2013 -104 +36.2 +25.9% Sep 30, 2013
Q2 2013 -104 +32.5 +23.8% Jun 30, 2013
Q1 2013 -105 +34.1 +24.5% Mar 31, 2013
Q4 2012 -132 -53.2 -67.9% Dec 31, 2012
Q3 2012 -140 Sep 30, 2012
Q2 2012 -137 Jun 30, 2012
Q1 2012 -139 Mar 31, 2012
Q4 2011 -78.3 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.